KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Sales (2017 - 2025)

Historic Return on Sales for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 1.15%.

  • Bionano Genomics' Return on Sales rose 61300.0% to 1.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.34%, marking a year-over-year increase of 27300.0%. This contributed to the annual value of 3.64% for FY2024, which is 28000.0% up from last year.
  • Bionano Genomics' Return on Sales amounted to 1.15% in Q3 2025, which was up 61300.0% from 1.02% recorded in Q2 2025.
  • Bionano Genomics' 5-year Return on Sales high stood at 0.48% for Q1 2025, and its period low was 12.08% during Q3 2023.
  • Moreover, its 5-year median value for Return on Sales was 4.41% (2022), whereas its average is 4.16%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -76800bps in 2023, then surged by 61300bps in 2025.
  • Quarter analysis of 5 years shows Bionano Genomics' Return on Sales stood at 3.64% in 2021, then dropped by -29bps to 4.71% in 2022, then increased by 13bps to 4.09% in 2023, then soared by 40bps to 2.47% in 2024, then soared by 53bps to 1.15% in 2025.
  • Its last three reported values are 1.15% in Q3 2025, 1.02% for Q2 2025, and 0.48% during Q1 2025.